| Revista: | Annals of hepatology |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000418130 |
| ISSN: | 1665-2681 |
| Autores: | Abenavoli, Ludovico1 Milic, Natasa2 Beaugrand3 |
| Instituciones: | 1Universita Magna Graecia, Department of Health Sciences, Catanzaro, Calabria. Italia 2University of Novi Sad, Department of Pharmacy, Novi Sad. Serbia 3Hopital Jean Verdier, Service d’Hepato-Gastroenterologie, Bondy, Seine-Saint-Denis. Francia |
| Año: | 2013 |
| Periodo: | Feb |
| Volumen: | 12 |
| Número: | 1 |
| Paginación: | 152-155 |
| País: | México |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Caso clínico, analítico |
| Resumen en inglés | Cyproterone acetate (CPA) is an oral anti-androgen commonly used to treat advanced prostate cancer. A variety of hepatotoxic reactions has been reported with CPA. Here we describe a case of a male patient who developed severe drug-induced hepatotoxicity during the treatment with CPA. The case, presenting sub-acute hepatitis, was characterized by a rapid evolution of cirrhosis and a protracted activity during the period of a few months despite the treatment withdrawal and an apparent benefits of corticosteroids, suggesting their indication in life threatening cases |
| Disciplinas: | Medicina |
| Palabras clave: | Gastroenterología, Farmacología, Hepatotoxicidad, Prednisona, Budesonida, Hepatitis crónica de interface, Corticosteroides |
| Keyword: | Gastroenterology, Pharmacology, Hepatotoxicity, Prednisone, Budesonide, Interface hepatitis, Corticosteroids |
| Texto completo: | Texto completo (Ver HTML) |
